No Data
No Data
Noble Financial Maintains GeoVax Labs(GOVX.US) With Buy Rating, Maintains Target Price $12
GeoVax Labs, Inc. Secures U.S. Patent Notice of Allowance for Tumor Immunotherapy Technology
GeoVax Receives Notice of Allowance For Cancer Vaccine Patent
Express News | GeoVax Receives Notice of Allowance for Cancer Vaccine Patent
GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference
Express News | World Health Organization Says Mpox Continues To Constitute A Public Health Emergency Of International Concern
No Data